Abstract:The Th17 cell subset is involved in many autoimmune and infectious pathologies. It is also associated with the tumorigenesis process and poor prognosis of certain tumors. However, its expression and function in glioma cases remain unclear. We measured the percentage of Th17 cells in peripheral blood mononuclear cells (PBMCs) and compared the concentrations of relevant cytokines in the serum of 35 glioma patients and 20 healthy donors. Protein, mRNA, and levels of Th17-relevant cytokines in 24 glioma tissues and 5 cerebral trauma tissues were also assessed. We evaluated whether Th17-relevant cytokines were associated with the clinical stages of glioma. The results showed that there were no significant differences in the volume of Th17 cells in PBMCs and serum concentrations of interferon (IFN)-γ, interleukin (IL)-17, IL-6, IL-23, and TGF-β between glioma patients and healthy donors nor did these differences exist in patients with different clinical stages of glioma. Different expression patterns of Th17-relevant cytokines were observed in glioma tissues when compared to trauma tissues. High mRNA-positive ratios of IL-17 (19/24) and retinoid-related orphan receptor (RORC) (18/24) were observed in glioma tissues, but not in trauma tissues. Positive ratios of transforming growth factor (TGF)-β were higher in trauma tissues and glioma grade II than in glioma grade IV. IL-6, IFN-γ, and IL-1β showed high positive ratios, but showed no significant differences between trauma tissues or grades of glioma. None of the glioma and trauma tissues was positive for IL-23. High positive ratios of IL-17 in glioma tissue were confirmed via analysis of immunohistochemical staining. The results demonstrated that IL-17 and other Th17-relevant cytokines could be expressed in glioma tissues. IL-17 expression, the hallmark of Th17 cell subset, may play an important role in glioma tumorigenesis and progression.

The Role of Predominant Expression of Th2 Type Cytokines Gene in the Genesis and Development of Human Gliomas

The Study of Monitoring Mechanism of Immunologicai Escaping in Human Gliomas

[Significance of the Unbalanced Expression of Th1/Th2 Type Cytokines in Human Glioma].

[Influence of Adjustment of Balance of Th1/Th2 Type Cytokines on Proliferation of Glioma Cells].

Gene Expression of Immunosuppressive Factor TGFβ2 and TGFβ1in Human Glioma

The Profile of Th17 Subset in Glioma.

Expressions and significance of Th1 7 and Th22 cells in peripheral blood of patients with glioma

Expression and Significance of STAT3 and CyclinD1 in Human Neuroglioma

Expressions of IL-17 and IL-17R in human glioma

TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma

Expression and Significance of TGF-β1 and Its Type I Receptor ALK1 in Human Brain Glioma

Expression of p57~(kip2) and cyclin D1 in human glioma and its clinical significance

[Establishment of Malignant Progression Associated Gene Expression Profiles in Human Brain Glioma].

Role of Interleukin-6 in the Occurring and Developing of Human Gliomas

Expressions of p57~(kip2) and cyclin D2 proteins in human glioma and their clinical significances

Study of Correlation Between Expression of TGF-β_1 and Bfgf and Cellular Proliferation in Human Glioma

Clinical significance of FOXP3 expression in human gliomas

Expression and Clinical Significance of P57kip2 and P16 in Human Glioma

Expression of Interleukin 6,signal Transducer and Activator of Transcription 3 and Vascular Endothelial Growth Factor in Human Glioma and Their Relationship

The overexpression and clinical significance of TBX15 in human gliomas

Expression of HMGB1 gene and its clinical significance in human glioma: a Meta-analysis